Skip to main content
. Author manuscript; available in PMC: 2015 Jun 8.
Published in final edited form as: Clin Exp Allergy. 2015 Apr;45(4):767–778. doi: 10.1111/cea.12463

Figure 7.

Figure 7

Change in association between selected serum biomarkers and subjects before (Visit 1) and during exacerbation (Visit 2). Edge weight of serum biomarkers (FGF, GM-CSF, Fractalkine, and VEGF) in relation to control and CRSwNP subjects was calculated for Visit 1 and Visit 2. Data are presented as median (horizontal bars), quartiles (boxes) and range (vertical lines) of edge weight values. Significant differences are depicted by horizontal lines.